Novel motif:36: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(One intermediate revision by the same user not shown) | |||
Line 1: | Line 1: | ||
{ | |||
Latest revision as of 14:41, 9 September 2013
name: | motif36_AAGGAGRAN |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0007522 | visceral muscle development | 6.282301e-20 |
GO:0055009 | atrial cardiac muscle tissue morphogenesis | 1.543557e-19 |
GO:0007512 | adult heart development | 5.169555e-15 |
GO:0003009 | skeletal muscle contraction | 1.965885e-13 |
GO:0045110 | intermediate filament bundle assembly | 6.990440e-11 |
GO:0033693 | neurofilament bundle assembly | 2.338699e-9 |
GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin | 2.725703e-9 |
GO:0045109 | intermediate filament organization | 3.401610e-9 |
GO:0003230 | cardiac atrium development | 3.500610e-9 |
GO:0003209 | cardiac atrium morphogenesis | 4.651267e-9 |
GO:0048259 | regulation of receptor-mediated endocytosis | 5.050851e-9 |
GO:0030100 | regulation of endocytosis | 5.711508e-9 |
GO:0055010 | ventricular cardiac muscle tissue morphogenesis | 5.765427e-9 |
GO:0042137 | sequestering of neurotransmitter | 9.150888e-9 |
GO:0007379 | segment specification | 1.791383e-8 |
GO:0003229 | ventricular cardiac muscle tissue development | 2.789164e-8 |
GO:0045806 | negative regulation of endocytosis | 4.949216e-8 |
GO:0051298 | centrosome duplication | 9.036162e-8 |
GO:0048260 | positive regulation of receptor-mediated endocytosis | 1.013511e-7 |
GO:0050804 | regulation of synaptic transmission | 1.445084e-7 |
GO:0045103 | intermediate filament-based process | 5.133676e-7 |
GO:0044341 | sodium-dependent phosphate transport | 6.528765e-7 |
GO:0006098 | pentose-phosphate shunt | 8.276771e-7 |
GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter | 1.386515e-6 |
GO:0010625 | positive regulation of Schwann cell proliferation | 1.426508e-6 |
GO:0010916 | negative regulation of very-low-density lipoprotein particle clearance | 1.430754e-6 |
GO:0002027 | regulation of heart rate | 1.462739e-6 |
GO:0060696 | regulation of phospholipid catabolic process | 1.542567e-6 |
GO:0032425 | positive regulation of mismatch repair | 1.684913e-6 |
GO:0002889 | regulation of immunoglobulin mediated immune response | 1.892647e-6 |
GO:0002712 | regulation of B cell mediated immunity | 2.175094e-6 |
GO:0071316 | cellular response to nicotine | 2.222914e-6 |
GO:0006739 | NADP metabolic process | 2.481594e-6 |
GO:0014028 | notochord formation | 2.495866e-6 |
GO:0043462 | regulation of ATPase activity | 2.604227e-6 |
GO:0009712 | catechol-containing compound metabolic process | 2.758071e-6 |
GO:0006584 | catecholamine metabolic process | 3.554351e-6 |
GO:0002026 | regulation of the force of heart contraction | 3.902641e-6 |
GO:0015742 | alpha-ketoglutarate transport | 4.345924e-6 |
GO:0051293 | establishment of spindle localization | 5.032549e-6 |
GO:0010984 | regulation of lipoprotein particle clearance | 5.493763e-6 |
GO:0002921 | negative regulation of humoral immune response | 6.099089e-6 |
GO:0002251 | organ or tissue specific immune response | 7.018586e-6 |
GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin | 7.154450e-6 |
GO:0040001 | establishment of mitotic spindle localization | 7.820782e-6 |
GO:0044057 | regulation of system process | 7.828585e-6 |
GO:0048167 | regulation of synaptic plasticity | 8.341355e-6 |
GO:0045104 | intermediate filament cytoskeleton organization | 8.475221e-6 |
GO:0031444 | slow-twitch skeletal muscle fiber contraction | 8.585026e-6 |
GO:0042415 | norepinephrine metabolic process | 9.125881e-6 |
GO:0060627 | regulation of vesicle-mediated transport | 1.327928e-5 |
GO:2000253 | positive regulation of feeding behavior | 1.453374e-5 |
GO:2000507 | positive regulation of energy homeostasis | 1.453374e-5 |
GO:0000132 | establishment of mitotic spindle orientation | 1.584658e-5 |
GO:0045945 | positive regulation of transcription from RNA polymerase III promoter | 1.689673e-5 |
GO:0002037 | negative regulation of L-glutamate transport | 1.743587e-5 |
GO:0045994 | positive regulation of translational initiation by iron | 1.743587e-5 |
GO:0035881 | amacrine cell differentiation | 1.900778e-5 |
GO:0048332 | mesoderm morphogenesis | 1.927198e-5 |
GO:0002036 | regulation of L-glutamate transport | 1.934175e-5 |
GO:0042220 | response to cocaine | 1.969819e-5 |
GO:0051956 | negative regulation of amino acid transport | 2.013605e-5 |
GO:0015760 | glucose-6-phosphate transport | 2.056522e-5 |
GO:0000302 | response to reactive oxygen species | 2.090430e-5 |
GO:0002876 | positive regulation of chronic inflammatory response to antigenic stimulus | 2.130659e-5 |
GO:0032933 | SREBP-mediated signaling pathway | 2.135460e-5 |
GO:0006740 | NADPH regeneration | 2.166228e-5 |
GO:0010735 | positive regulation of transcription via serum response element binding | 2.200492e-5 |
GO:0032796 | uropod organization | 2.238291e-5 |
GO:0046015 | regulation of transcription by glucose | 2.238291e-5 |
GO:0032846 | positive regulation of homeostatic process | 2.273305e-5 |
GO:0032423 | regulation of mismatch repair | 2.424676e-5 |
GO:0010867 | positive regulation of triglyceride biosynthetic process | 2.483823e-5 |
GO:0071407 | cellular response to organic cyclic compound | 2.665294e-5 |
GO:0006447 | regulation of translational initiation by iron | 2.801429e-5 |
GO:0001707 | mesoderm formation | 3.007439e-5 |
GO:0006620 | posttranslational protein targeting to membrane | 3.008829e-5 |
GO:0070309 | lens fiber cell morphogenesis | 3.159191e-5 |
GO:0010985 | negative regulation of lipoprotein particle clearance | 3.303967e-5 |
GO:0030826 | regulation of cGMP biosynthetic process | 3.326053e-5 |
GO:0000414 | regulation of histone H3-K36 methylation | 3.353098e-5 |
GO:0045717 | negative regulation of fatty acid biosynthetic process | 3.365394e-5 |
GO:0048251 | elastic fiber assembly | 3.769080e-5 |
GO:0051955 | regulation of amino acid transport | 3.801456e-5 |
GO:0010900 | negative regulation of phosphatidylcholine catabolic process | 3.874035e-5 |
GO:0014910 | regulation of smooth muscle cell migration | 4.065350e-5 |
GO:0000432 | positive regulation of transcription from RNA polymerase II promoter by glucose | 4.420099e-5 |
GO:0021562 | vestibulocochlear nerve development | 4.527995e-5 |
GO:0071712 | ER-associated misfolded protein catabolic process | 4.910862e-5 |
GO:0034378 | chylomicron assembly | 6.173406e-5 |
GO:0051126 | negative regulation of actin nucleation | 6.173406e-5 |
GO:0050881 | musculoskeletal movement | 6.231241e-5 |
GO:0051569 | regulation of histone H3-K4 methylation | 6.386584e-5 |
GO:0051971 | positive regulation of transmission of nerve impulse | 6.437961e-5 |
GO:0007616 | long-term memory | 6.496942e-5 |
GO:0060035 | notochord cell development | 6.635528e-5 |
GO:0031296 | B cell costimulation | 6.635528e-5 |
GO:0045471 | response to ethanol | 6.678932e-5 |
GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin | 6.801047e-5 |
GO:0002021 | response to dietary excess | 7.267669e-5 |
GO:0006939 | smooth muscle contraction | 7.485069e-5 |
GO:0050806 | positive regulation of synaptic transmission | 7.757797e-5 |
GO:0007569 | cell aging | 7.799506e-5 |
GO:0030844 | positive regulation of intermediate filament depolymerization | 8.095207e-5 |
GO:0003231 | cardiac ventricle development | 8.133411e-5 |
GO:0006936 | muscle contraction | 8.894861e-5 |
GO:0032862 | activation of Rho GTPase activity | 9.457498e-5 |
GO:0085029 | extracellular matrix assembly | 9.457498e-5 |
GO:0002227 | innate immune response in mucosa | 9.817433e-5 |
GO:0048008 | platelet-derived growth factor receptor signaling pathway | 1.004927e-4 |
GO:0042823 | pyridoxal phosphate biosynthetic process | 1.145705e-4 |
GO:0060561 | apoptosis involved in morphogenesis | 1.196325e-4 |
GO:0051054 | positive regulation of DNA metabolic process | 1.197213e-4 |
GO:0010664 | negative regulation of striated muscle cell apoptosis | 1.201054e-4 |
GO:0071392 | cellular response to estradiol stimulus | 1.274189e-4 |
GO:0003206 | cardiac chamber morphogenesis | 1.280118e-4 |
GO:0019896 | axon transport of mitochondrion | 1.388224e-4 |
GO:2000505 | regulation of energy homeostasis | 1.446323e-4 |
GO:0045136 | development of secondary sexual characteristics | 1.464770e-4 |
GO:0001808 | negative regulation of type IV hypersensitivity | 1.541236e-4 |
GO:0042538 | hyperosmotic salinity response | 1.596543e-4 |
GO:0032792 | negative regulation of CREB transcription factor activity | 1.621582e-4 |
GO:0015851 | nucleobase transport | 1.649029e-4 |
GO:0050909 | sensory perception of taste | 1.676963e-4 |
GO:0042696 | menarche | 1.735569e-4 |
GO:0048598 | embryonic morphogenesis | 1.746390e-4 |
GO:2000278 | regulation of DNA biosynthetic process | 1.781639e-4 |
GO:0007613 | memory | 1.786542e-4 |
GO:0035105 | sterol regulatory element binding protein import into nucleus | 1.832195e-4 |
GO:0003002 | regionalization | 1.852486e-4 |
GO:0003205 | cardiac chamber development | 1.897415e-4 |
GO:0009790 | embryo development | 1.913084e-4 |
GO:0048168 | regulation of neuronal synaptic plasticity | 2.014218e-4 |
GO:0055012 | ventricular cardiac muscle cell differentiation | 2.162213e-4 |
GO:0071624 | positive regulation of granulocyte chemotaxis | 2.248102e-4 |
GO:0050829 | defense response to Gram-negative bacterium | 2.278570e-4 |
GO:0050764 | regulation of phagocytosis | 2.288013e-4 |
GO:0061048 | negative regulation of branching involved in lung morphogenesis | 2.320449e-4 |
GO:0060676 | ureteric bud formation | 2.338370e-4 |
GO:0046543 | development of secondary female sexual characteristics | 2.372388e-4 |
GO:0051130 | positive regulation of cellular component organization | 2.387414e-4 |
GO:0051125 | regulation of actin nucleation | 2.471344e-4 |
GO:0007098 | centrosome cycle | 2.495753e-4 |
GO:0002920 | regulation of humoral immune response | 2.532711e-4 |
GO:0006463 | steroid hormone receptor complex assembly | 2.548125e-4 |
GO:0002676 | regulation of chronic inflammatory response | 2.612619e-4 |
GO:0045807 | positive regulation of endocytosis | 2.619680e-4 |
GO:0090398 | cellular senescence | 2.664573e-4 |
GO:0090400 | stress-induced premature senescence | 2.665639e-4 |
GO:0009450 | gamma-aminobutyric acid catabolic process | 2.679305e-4 |
GO:0043270 | positive regulation of ion transport | 2.764290e-4 |
GO:0019086 | late viral mRNA transcription | 2.768022e-4 |
GO:0060313 | negative regulation of blood vessel remodeling | 2.787176e-4 |
GO:0060311 | negative regulation of elastin catabolic process | 2.787176e-4 |
GO:0010703 | negative regulation of histolysis | 2.787176e-4 |
GO:0010711 | negative regulation of collagen catabolic process | 2.787176e-4 |
GO:0003208 | cardiac ventricle morphogenesis | 2.927512e-4 |
GO:0030010 | establishment of cell polarity | 2.958022e-4 |
GO:2000097 | regulation of smooth muscle cell-matrix adhesion | 2.963217e-4 |
GO:0001704 | formation of primary germ layer | 3.017304e-4 |
GO:0031536 | positive regulation of exit from mitosis | 3.255265e-4 |
GO:2000098 | negative regulation of smooth muscle cell-matrix adhesion | 3.295627e-4 |
GO:0071258 | cellular response to gravity | 3.295627e-4 |
GO:0035491 | positive regulation of leukotriene production involved in inflammatory response | 3.295627e-4 |
GO:0061044 | negative regulation of vascular wound healing | 3.295627e-4 |
GO:0071312 | cellular response to alkaloid | 3.416312e-4 |
GO:0019321 | pentose metabolic process | 3.477401e-4 |
GO:0051297 | centrosome organization | 3.518719e-4 |
GO:0019693 | ribose phosphate metabolic process | 3.572678e-4 |
GO:0043084 | penile erection | 3.575813e-4 |
GO:0050830 | defense response to Gram-positive bacterium | 3.723140e-4 |
GO:0018198 | peptidyl-cysteine modification | 3.732602e-4 |
GO:0001757 | somite specification | 3.762068e-4 |
GO:0050765 | negative regulation of phagocytosis | 4.088319e-4 |
GO:0051588 | regulation of neurotransmitter transport | 4.165993e-4 |
GO:0034389 | lipid particle organization | 4.239699e-4 |
GO:0008089 | anterograde axon cargo transport | 4.253943e-4 |
GO:0061143 | alveolar primary septum development | 4.291440e-4 |
GO:0044342 | type B pancreatic cell proliferation | 4.291440e-4 |
GO:0010918 | positive regulation of mitochondrial membrane potential | 4.291440e-4 |
GO:0015680 | intracellular copper ion transport | 4.291440e-4 |
GO:0002891 | positive regulation of immunoglobulin mediated immune response | 4.406480e-4 |
GO:0007612 | learning | 4.614899e-4 |
GO:0046732 | active induction of host immune response by virus | 4.654374e-4 |
GO:0033601 | positive regulation of mammary gland epithelial cell proliferation | 4.679221e-4 |
GO:0002385 | mucosal immune response | 4.778394e-4 |
GO:0045922 | negative regulation of fatty acid metabolic process | 4.835430e-4 |
GO:0009952 | anterior/posterior pattern specification | 4.903416e-4 |
GO:0015866 | ADP transport | 5.024930e-4 |
GO:0007589 | body fluid secretion | 5.025860e-4 |
GO:0042304 | regulation of fatty acid biosynthetic process | 5.358223e-4 |
GO:0002678 | positive regulation of chronic inflammatory response | 5.456957e-4 |
GO:0070587 | regulation of cell-cell adhesion involved in gastrulation | 5.522916e-4 |
GO:0034114 | regulation of heterotypic cell-cell adhesion | 5.522916e-4 |
GO:0032274 | gonadotropin secretion | 5.561647e-4 |
GO:0010713 | negative regulation of collagen metabolic process | 5.793616e-4 |
GO:0010523 | negative regulation of calcium ion transport into cytosol | 5.818768e-4 |
GO:0006112 | energy reserve metabolic process | 5.924527e-4 |
GO:0050890 | cognition | 6.120939e-4 |
GO:0060052 | neurofilament cytoskeleton organization | 6.133065e-4 |
GO:0090207 | regulation of triglyceride metabolic process | 6.246137e-4 |
GO:0035606 | peptidyl-cysteine S-trans-nitrosylation | 6.272069e-4 |
GO:0042447 | hormone catabolic process | 6.321615e-4 |
GO:0032863 | activation of Rac GTPase activity | 6.519615e-4 |
GO:0045299 | otolith mineralization | 6.736957e-4 |
GO:0010866 | regulation of triglyceride biosynthetic process | 6.818633e-4 |
GO:0060123 | regulation of growth hormone secretion | 6.998927e-4 |
GO:0021766 | hippocampus development | 7.013633e-4 |
GO:0050432 | catecholamine secretion | 7.406642e-4 |
GO:0046341 | CDP-diacylglycerol metabolic process | 7.417394e-4 |
GO:0001807 | regulation of type IV hypersensitivity | 7.417394e-4 |
GO:0048680 | positive regulation of axon regeneration | 7.432150e-4 |
GO:0060252 | positive regulation of glial cell proliferation | 7.668088e-4 |
GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation | 7.803216e-4 |
GO:2000210 | positive regulation of anoikis | 8.047667e-4 |
GO:0032780 | negative regulation of ATPase activity | 8.140842e-4 |
GO:0021528 | commissural neuron differentiation in spinal cord | 8.186507e-4 |
GO:2000303 | regulation of ceramide biosynthetic process | 8.284805e-4 |
GO:0009052 | pentose-phosphate shunt, non-oxidative branch | 8.328421e-4 |
GO:0031646 | positive regulation of neurological system process | 8.753744e-4 |
GO:2000491 | positive regulation of hepatic stellate cell activation | 9.028298e-4 |
GO:0009651 | response to salt stress | 9.095721e-4 |
GO:0071394 | cellular response to testosterone stimulus | 9.147771e-4 |
GO:0090208 | positive regulation of triglyceride metabolic process | 9.154655e-4 |
GO:0070904 | transepithelial L-ascorbic acid transport | 9.382649e-4 |
GO:0060996 | dendritic spine development | 9.605686e-4 |
GO:0090072 | positive regulation of sodium ion transport via voltage-gated sodium channel activity | 9.749272e-4 |
GO:0022038 | corpus callosum development | 9.768225e-4 |
GO:0048261 | negative regulation of receptor-mediated endocytosis | 1.013208e-3 |
GO:0003278 | apoptosis involved in heart morphogenesis | 1.019523e-3 |
GO:0018277 | protein deamination | 1.022264e-3 |
GO:0046884 | follicle-stimulating hormone secretion | 1.064914e-3 |
GO:0032275 | luteinizing hormone secretion | 1.064914e-3 |
GO:0000416 | positive regulation of histone H3-K36 methylation | 1.064914e-3 |
GO:0060430 | lung saccule development | 1.083454e-3 |
GO:0060124 | positive regulation of growth hormone secretion | 1.105808e-3 |
GO:0051532 | regulation of NFAT protein import into nucleus | 1.113415e-3 |
GO:0015853 | adenine transport | 1.123966e-3 |
GO:0043243 | positive regulation of protein complex disassembly | 1.195618e-3 |
GO:0060992 | response to fungicide | 1.205450e-3 |
GO:0035307 | positive regulation of protein dephosphorylation | 1.205450e-3 |
GO:0060612 | adipose tissue development | 1.214856e-3 |
GO:0021570 | rhombomere 4 development | 1.232465e-3 |
GO:0051004 | regulation of lipoprotein lipase activity | 1.245246e-3 |
GO:0010561 | negative regulation of glycoprotein biosynthetic process | 1.246570e-3 |
GO:0010524 | positive regulation of calcium ion transport into cytosol | 1.252546e-3 |
GO:0051280 | negative regulation of release of sequestered calcium ion into cytosol | 1.258867e-3 |
GO:0045943 | positive regulation of transcription from RNA polymerase I promoter | 1.258867e-3 |
GO:0009817 | defense response to fungus, incompatible interaction | 1.258867e-3 |
GO:0010667 | negative regulation of cardiac muscle cell apoptosis | 1.270804e-3 |
GO:0042766 | nucleosome mobilization | 1.275470e-3 |
GO:2000304 | positive regulation of ceramide biosynthetic process | 1.318507e-3 |
GO:0048839 | inner ear development | 1.319497e-3 |
GO:0048630 | skeletal muscle tissue growth | 1.319528e-3 |
GO:0035066 | positive regulation of histone acetylation | 1.347729e-3 |
GO:0071287 | cellular response to manganese ion | 1.355555e-3 |
GO:0070633 | transepithelial transport | 1.385417e-3 |
GO:0002513 | tolerance induction to self antigen | 1.387598e-3 |
GO:0003012 | muscle system process | 1.389189e-3 |
GO:0007635 | chemosensory behavior | 1.419928e-3 |
GO:0007611 | learning or memory | 1.424055e-3 |
GO:0072081 | specification of nephron tubule identity | 1.429207e-3 |
GO:0006927 | transformed cell apoptosis | 1.463101e-3 |
GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway | 1.467158e-3 |
GO:0010350 | cellular response to magnesium starvation | 1.484654e-3 |
GO:0021919 | BMP signaling pathway involved in spinal cord dorsal/ventral patterning | 1.521201e-3 |
GO:0009235 | cobalamin metabolic process | 1.521201e-3 |
GO:0070625 | zymogen granule exocytosis | 1.562200e-3 |
GO:0014005 | microglia development | 1.562200e-3 |
GO:0010225 | response to UV-C | 1.569312e-3 |
GO:0050912 | detection of chemical stimulus involved in sensory perception of taste | 1.615611e-3 |
GO:0061302 | smooth muscle cell-matrix adhesion | 1.615850e-3 |
GO:0032805 | positive regulation of low-density lipoprotein particle receptor catabolic process | 1.615850e-3 |
GO:0048752 | semicircular canal morphogenesis | 1.626003e-3 |
GO:0021508 | floor plate formation | 1.633403e-3 |
GO:0071549 | cellular response to dexamethasone stimulus | 1.653469e-3 |
GO:0035417 | negative regulation of mitotic prometaphase | 1.655532e-3 |
GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning | 1.655532e-3 |
GO:0002502 | peptide antigen assembly with MHC class I protein complex | 1.655532e-3 |
GO:0033504 | floor plate development | 1.670108e-3 |
GO:0006513 | protein monoubiquitination | 1.684363e-3 |
GO:0006685 | sphingomyelin catabolic process | 1.729609e-3 |
GO:0010765 | positive regulation of sodium ion transport | 1.764087e-3 |
GO:0060997 | dendritic spine morphogenesis | 1.780028e-3 |
GO:0006525 | arginine metabolic process | 1.817735e-3 |
GO:0035094 | response to nicotine | 1.875500e-3 |
GO:0043279 | response to alkaloid | 1.889416e-3 |
GO:0061043 | regulation of vascular wound healing | 1.979371e-3 |
GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway | 1.979371e-3 |
GO:0008306 | associative learning | 2.002909e-3 |
GO:0030853 | negative regulation of granulocyte differentiation | 2.022172e-3 |
GO:0048705 | skeletal system morphogenesis | 2.042897e-3 |
GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity | 2.077800e-3 |
GO:0072086 | specification of loop of Henle identity | 2.103215e-3 |
GO:0045988 | negative regulation of striated muscle contraction | 2.107711e-3 |
GO:0032231 | regulation of actin filament bundle assembly | 2.124865e-3 |
GO:0009074 | aromatic amino acid family catabolic process | 2.126111e-3 |
GO:0030828 | positive regulation of cGMP biosynthetic process | 2.140039e-3 |
GO:0043314 | negative regulation of neutrophil degranulation | 2.140039e-3 |
GO:0090303 | positive regulation of wound healing | 2.140102e-3 |
GO:0007369 | gastrulation | 2.148321e-3 |
GO:0051533 | positive regulation of NFAT protein import into nucleus | 2.157315e-3 |
GO:0060037 | pharyngeal system development | 2.175052e-3 |
GO:0014060 | regulation of epinephrine secretion | 2.185191e-3 |
GO:0031644 | regulation of neurological system process | 2.208650e-3 |
GO:0006014 | D-ribose metabolic process | 2.255703e-3 |
GO:0023061 | signal release | 2.275707e-3 |
GO:0008016 | regulation of heart contraction | 2.285458e-3 |
GO:2000696 | regulation of epithelial cell differentiation involved in kidney development | 2.307788e-3 |
GO:0010529 | negative regulation of transposition | 2.352741e-3 |
GO:0048199 | vesicle targeting, to, from or within Golgi | 2.385477e-3 |
GO:0060291 | long-term synaptic potentiation | 2.385477e-3 |
GO:0044319 | wound healing, spreading of cells | 2.432437e-3 |
GO:0051014 | actin filament severing | 2.457304e-3 |
GO:0009443 | pyridoxal 5'-phosphate salvage | 2.488139e-3 |
GO:0072176 | nephric duct development | 2.495604e-3 |
GO:0060154 | cellular process regulating host cell cycle in response to virus | 2.498849e-3 |
GO:0035883 | enteroendocrine cell differentiation | 2.513114e-3 |
GO:0019439 | aromatic compound catabolic process | 2.518390e-3 |
GO:0007501 | mesodermal cell fate specification | 2.531524e-3 |
GO:0045833 | negative regulation of lipid metabolic process | 2.533294e-3 |
GO:0043583 | ear development | 2.541605e-3 |
GO:0043001 | Golgi to plasma membrane protein transport | 2.602054e-3 |
GO:0048242 | epinephrine secretion | 2.612665e-3 |
GO:2000466 | negative regulation of glycogen (starch) synthase activity | 2.614333e-3 |
GO:0035771 | interleukin-4-mediated signaling pathway | 2.614333e-3 |
GO:0060444 | branching involved in mammary gland duct morphogenesis | 2.636404e-3 |
GO:0051572 | negative regulation of histone H3-K4 methylation | 2.699549e-3 |
GO:0050819 | negative regulation of coagulation | 2.796421e-3 |
GO:0014912 | negative regulation of smooth muscle cell migration | 2.798608e-3 |
GO:0060555 | induction of necroptosis by extracellular signals | 2.805591e-3 |
GO:0001955 | blood vessel maturation | 2.836177e-3 |
GO:0032856 | activation of Ras GTPase activity | 2.871833e-3 |
GO:0021569 | rhombomere 3 development | 2.873862e-3 |
GO:0021599 | abducens nerve formation | 2.879292e-3 |
GO:0007634 | optokinetic behavior | 2.879292e-3 |
GO:0055015 | ventricular cardiac muscle cell development | 2.888527e-3 |
GO:0008217 | regulation of blood pressure | 2.892251e-3 |
GO:0030195 | negative regulation of blood coagulation | 2.958096e-3 |
GO:0072537 | fibroblast activation | 2.981073e-3 |
GO:0007136 | meiotic prophase II | 2.981073e-3 |
GO:0033505 | floor plate morphogenesis | 2.992728e-3 |
GO:0072178 | nephric duct morphogenesis | 2.999288e-3 |
GO:0072040 | negative regulation of mesenchymal stem cell apoptosis involved in nephron morphogenesis | 2.999996e-3 |
GO:0010638 | positive regulation of organelle organization | 3.101792e-3 |
GO:0002384 | hepatic immune response | 3.172429e-3 |
GO:0016486 | peptide hormone processing | 3.183361e-3 |
GO:0003017 | lymph circulation | 3.187219e-3 |
GO:0032233 | positive regulation of actin filament bundle assembly | 3.249809e-3 |
GO:0046902 | regulation of mitochondrial membrane permeability | 3.328654e-3 |
GO:0009880 | embryonic pattern specification | 3.398742e-3 |
GO:0051928 | positive regulation of calcium ion transport | 3.413008e-3 |
GO:0031058 | positive regulation of histone modification | 3.459107e-3 |
GO:0009048 | dosage compensation, by inactivation of X chromosome | 3.480989e-3 |
GO:0006901 | vesicle coating | 3.491503e-3 |
GO:0035306 | positive regulation of dephosphorylation | 3.493892e-3 |
GO:0051208 | sequestering of calcium ion | 3.518270e-3 |
GO:0061178 | regulation of insulin secretion involved in cellular response to glucose stimulus | 3.521127e-3 |
GO:0050850 | positive regulation of calcium-mediated signaling | 3.546315e-3 |
GO:0021603 | cranial nerve formation | 3.549339e-3 |
GO:0060259 | regulation of feeding behavior | 3.564079e-3 |
GO:0046889 | positive regulation of lipid biosynthetic process | 3.592580e-3 |
GO:0032753 | positive regulation of interleukin-4 production | 3.655733e-3 |
GO:0042593 | glucose homeostasis | 3.693683e-3 |
GO:0070141 | response to UV-A | 3.700424e-3 |
GO:2000016 | negative regulation of determination of dorsal identity | 3.705187e-3 |
GO:0060003 | copper ion export | 3.705187e-3 |
GO:0015677 | copper ion import | 3.705187e-3 |
GO:0030327 | prenylated protein catabolic process | 3.705187e-3 |
GO:0000271 | polysaccharide biosynthetic process | 3.720854e-3 |
GO:0019062 | virion attachment to host cell surface receptor | 3.727927e-3 |
GO:0071109 | superior temporal gyrus development | 3.769619e-3 |
GO:0065001 | specification of axis polarity | 3.783004e-3 |
GO:0051969 | regulation of transmission of nerve impulse | 3.808863e-3 |
GO:0019322 | pentose biosynthetic process | 3.837694e-3 |
GO:0006570 | tyrosine metabolic process | 3.885259e-3 |
GO:0006527 | arginine catabolic process | 3.893534e-3 |
GO:0021877 | forebrain neuron fate commitment | 3.894339e-3 |
GO:0048845 | venous blood vessel morphogenesis | 3.913301e-3 |
GO:0032204 | regulation of telomere maintenance | 3.937657e-3 |
GO:0007296 | vitellogenesis | 3.990416e-3 |
GO:0002439 | chronic inflammatory response to antigenic stimulus | 4.026099e-3 |
GO:0035356 | cellular triglyceride homeostasis | 4.188603e-3 |
GO:0072107 | positive regulation of ureteric bud formation | 4.190096e-3 |
GO:0018119 | peptidyl-cysteine S-nitrosylation | 4.212882e-3 |
GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process | 4.230485e-3 |
GO:0072385 | minus-end-directed organelle transport along microtubule | 4.286935e-3 |
GO:0043901 | negative regulation of multi-organism process | 4.310659e-3 |
GO:0010390 | histone monoubiquitination | 4.344774e-3 |
GO:0050995 | negative regulation of lipid catabolic process | 4.398234e-3 |
GO:0001505 | regulation of neurotransmitter levels | 4.435739e-3 |
GO:0051055 | negative regulation of lipid biosynthetic process | 4.442046e-3 |
GO:0044130 | negative regulation of growth of symbiont in host | 4.505438e-3 |
GO:0006559 | L-phenylalanine catabolic process | 4.541383e-3 |
GO:0006684 | sphingomyelin metabolic process | 4.684470e-3 |
GO:0071218 | cellular response to misfolded protein | 4.686626e-3 |
GO:0042472 | inner ear morphogenesis | 4.734935e-3 |
GO:0045616 | regulation of keratinocyte differentiation | 4.745530e-3 |
GO:0016574 | histone ubiquitination | 4.773701e-3 |
GO:0018125 | peptidyl-cysteine methylation | 4.783645e-3 |
GO:0005981 | regulation of glycogen catabolic process | 4.803727e-3 |
GO:2000209 | regulation of anoikis | 4.818378e-3 |
GO:0002862 | negative regulation of inflammatory response to antigenic stimulus | 4.824100e-3 |
GO:0070102 | interleukin-6-mediated signaling pathway | 4.828808e-3 |
GO:0031062 | positive regulation of histone methylation | 4.836955e-3 |
GO:0043491 | protein kinase B signaling cascade | 4.896908e-3 |
GO:0043903 | regulation of symbiosis, encompassing mutualism through parasitism | 4.952597e-3 |
GO:0040040 | thermosensory behavior | 4.984310e-3 |
GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway | 5.021570e-3 |
GO:0006711 | estrogen catabolic process | 5.104796e-3 |
GO:0007269 | neurotransmitter secretion | 5.111922e-3 |
GO:0003184 | pulmonary valve morphogenesis | 5.159190e-3 |
GO:0019318 | hexose metabolic process | 5.172015e-3 |
GO:0007263 | nitric oxide mediated signal transduction | 5.206061e-3 |
GO:0003180 | aortic valve morphogenesis | 5.228791e-3 |
GO:0051970 | negative regulation of transmission of nerve impulse | 5.259048e-3 |
GO:0032855 | positive regulation of Rac GTPase activity | 5.270201e-3 |
GO:0010536 | positive regulation of activation of Janus kinase activity | 5.338399e-3 |
GO:0007498 | mesoderm development | 5.343263e-3 |
GO:0007435 | salivary gland morphogenesis | 5.379178e-3 |
GO:0042421 | norepinephrine biosynthetic process | 5.388536e-3 |
GO:0033599 | regulation of mammary gland epithelial cell proliferation | 5.499918e-3 |
GO:2000054 | negative regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification | 5.523442e-3 |
GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity | 5.536562e-3 |
GO:0030540 | female genitalia development | 5.619101e-3 |
GO:0006825 | copper ion transport | 5.637412e-3 |
GO:0032464 | positive regulation of protein homooligomerization | 5.641059e-3 |
GO:0043128 | positive regulation of 1-phosphatidylinositol 4-kinase activity | 5.645082e-3 |
GO:0009436 | glyoxylate catabolic process | 5.688614e-3 |
GO:0022417 | protein maturation by protein folding | 5.871116e-3 |
GO:0023021 | termination of signal transduction | 5.939205e-3 |
GO:0021759 | globus pallidus development | 5.939205e-3 |
GO:0003108 | negative regulation of the force of heart contraction by chemical signal | 5.939205e-3 |
GO:0048562 | embryonic organ morphogenesis | 5.979665e-3 |
GO:0046684 | response to pyrethroid | 6.070948e-3 |
GO:0050832 | defense response to fungus | 6.074621e-3 |
GO:0060370 | susceptibility to T cell mediated cytotoxicity | 6.103805e-3 |
GO:0006493 | protein O-linked glycosylation | 6.134907e-3 |
GO:0051402 | neuron apoptosis | 6.152867e-3 |
GO:0035048 | splicing factor protein import into nucleus | 6.250484e-3 |
GO:0000415 | negative regulation of histone H3-K36 methylation | 6.323062e-3 |
GO:0072657 | protein localization in membrane | 6.471946e-3 |
GO:0046814 | virion attachment, binding of host cell surface coreceptor | 6.489380e-3 |
GO:0051898 | negative regulation of protein kinase B signaling cascade | 6.499462e-3 |
GO:0051241 | negative regulation of multicellular organismal process | 6.630143e-3 |
GO:0071354 | cellular response to interleukin-6 | 6.634269e-3 |
GO:0010712 | regulation of collagen metabolic process | 6.650725e-3 |
GO:0060928 | atrioventricular node cell development | 6.707501e-3 |
GO:0090222 | centrosome-templated microtubule nucleation | 6.707501e-3 |
GO:0060929 | atrioventricular node cell fate commitment | 6.707501e-3 |
GO:0003342 | proepicardium development | 6.707501e-3 |
GO:0003168 | cardiac Purkinje fiber cell differentiation | 6.707501e-3 |
GO:0055014 | atrial cardiac muscle cell development | 6.712009e-3 |
GO:0042819 | vitamin B6 biosynthetic process | 6.712009e-3 |
GO:0030836 | positive regulation of actin filament depolymerization | 6.716311e-3 |
GO:0008078 | mesodermal cell migration | 6.739040e-3 |
GO:0008090 | retrograde axon cargo transport | 6.764067e-3 |
GO:0009635 | response to herbicide | 6.789465e-3 |
GO:0045940 | positive regulation of steroid metabolic process | 6.804188e-3 |
GO:0045932 | negative regulation of muscle contraction | 6.822544e-3 |
GO:0048208 | COPII vesicle coating | 6.831602e-3 |
GO:0060073 | micturition | 6.978948e-3 |
GO:0031295 | T cell costimulation | 7.067157e-3 |
GO:0043313 | regulation of neutrophil degranulation | 7.132684e-3 |
GO:0046426 | negative regulation of JAK-STAT cascade | 7.223255e-3 |
GO:0051580 | regulation of neurotransmitter uptake | 7.223255e-3 |
GO:0021702 | cerebellar Purkinje cell differentiation | 7.230515e-3 |
GO:2000623 | negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 7.236467e-3 |
GO:0031167 | rRNA methylation | 7.236467e-3 |
GO:0010940 | positive regulation of necrotic cell death | 7.335835e-3 |
GO:0031060 | regulation of histone methylation | 7.347133e-3 |
GO:2000543 | positive regulation of gastrulation | 7.381730e-3 |
GO:0022027 | interkinetic nuclear migration | 7.381730e-3 |
GO:0007595 | lactation | 7.410811e-3 |
GO:0044070 | regulation of anion transport | 7.511586e-3 |
GO:0002537 | nitric oxide production involved in inflammatory response | 7.585336e-3 |
GO:0002740 | negative regulation of cytokine secretion involved in immune response | 7.598676e-3 |
GO:0051764 | actin crosslink formation | 7.640152e-3 |
GO:0072089 | stem cell proliferation | 7.676273e-3 |
GO:0033158 | regulation of protein import into nucleus, translocation | 7.681915e-3 |
GO:0019054 | modulation by virus of host cellular process | 7.695788e-3 |
GO:0003062 | regulation of heart rate by chemical signal | 7.767901e-3 |
GO:0070842 | aggresome assembly | 7.767901e-3 |
GO:0030834 | regulation of actin filament depolymerization | 7.801186e-3 |
GO:0035725 | sodium ion transmembrane transport | 7.868118e-3 |
GO:0042088 | T-helper 1 type immune response | 7.910473e-3 |
GO:0009072 | aromatic amino acid family metabolic process | 7.934720e-3 |
GO:0046548 | retinal rod cell development | 7.957675e-3 |
GO:0045916 | negative regulation of complement activation | 8.000966e-3 |
GO:0051953 | negative regulation of amine transport | 8.003300e-3 |
GO:0050805 | negative regulation of synaptic transmission | 8.072064e-3 |
GO:0045721 | negative regulation of gluconeogenesis | 8.146831e-3 |
GO:0010821 | regulation of mitochondrion organization | 8.218933e-3 |
GO:0045736 | negative regulation of cyclin-dependent protein kinase activity | 8.267158e-3 |
GO:0060312 | regulation of blood vessel remodeling | 8.278468e-3 |
GO:0045575 | basophil activation | 8.278468e-3 |
GO:0001694 | histamine biosynthetic process | 8.278468e-3 |
GO:2000679 | positive regulation of transcription regulatory region DNA binding | 8.336685e-3 |
GO:0019064 | viral envelope fusion with host membrane | 8.399434e-3 |
GO:0071276 | cellular response to cadmium ion | 8.413613e-3 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0007522 | visceral muscle development | 9.656975e-21 |
GO:0055009 | atrial cardiac muscle tissue morphogenesis | 1.629740e-19 |
GO:0030049 | muscle filament sliding | 1.645712e-17 |
GO:0070646 | protein modification by small protein removal | 1.635661e-16 |
GO:0016579 | protein deubiquitination | 4.403158e-15 |
GO:0048739 | cardiac muscle fiber development | 6.063761e-15 |
GO:0031133 | regulation of axon diameter | 2.130573e-10 |
GO:0030509 | BMP signaling pathway | 2.255928e-10 |
GO:0048598 | embryonic morphogenesis | 3.965541e-9 |
GO:0009952 | anterior/posterior pattern specification | 4.349740e-9 |
GO:0032536 | regulation of cell projection size | 8.009055e-9 |
GO:0055010 | ventricular cardiac muscle tissue morphogenesis | 9.180435e-9 |
GO:0003002 | regionalization | 1.218701e-8 |
GO:0003209 | cardiac atrium morphogenesis | 2.364144e-8 |
GO:0043462 | regulation of ATPase activity | 3.189725e-8 |
GO:0002026 | regulation of the force of heart contraction | 6.787243e-8 |
GO:0006970 | response to osmotic stress | 7.533826e-8 |
GO:0003229 | ventricular cardiac muscle tissue development | 8.657000e-8 |
GO:0014056 | regulation of acetylcholine secretion | 8.865517e-8 |
GO:0048568 | embryonic organ development | 1.361029e-7 |
GO:0006941 | striated muscle contraction | 1.748105e-7 |
GO:0001702 | gastrulation with mouth forming second | 1.945602e-7 |
GO:0033275 | actin-myosin filament sliding | 2.097520e-7 |
GO:0007369 | gastrulation | 2.272443e-7 |
GO:0003230 | cardiac atrium development | 2.525085e-7 |
GO:0009950 | dorsal/ventral axis specification | 2.765667e-7 |
GO:0007389 | pattern specification process | 3.699136e-7 |
GO:0071371 | cellular response to gonadotropin stimulus | 4.913558e-7 |
GO:0048705 | skeletal system morphogenesis | 6.388368e-7 |
GO:0009798 | axis specification | 8.401266e-7 |
GO:2000053 | regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification | 9.143050e-7 |
GO:0048332 | mesoderm morphogenesis | 1.089129e-6 |
GO:0007281 | germ cell development | 1.689762e-6 |
GO:0070252 | actin-mediated cell contraction | 1.888552e-6 |
GO:0001707 | mesoderm formation | 1.896584e-6 |
GO:0016055 | Wnt receptor signaling pathway | 2.122736e-6 |
GO:0007213 | muscarinic acetylcholine receptor signaling pathway | 2.169979e-6 |
GO:0021707 | cerebellar granule cell differentiation | 2.277110e-6 |
GO:0021575 | hindbrain morphogenesis | 2.326935e-6 |
GO:0021871 | forebrain regionalization | 2.602920e-6 |
GO:0007398 | ectoderm development | 4.425361e-6 |
GO:0021797 | forebrain anterior/posterior pattern specification | 4.456967e-6 |
GO:0010595 | positive regulation of endothelial cell migration | 4.547903e-6 |
GO:0071456 | cellular response to hypoxia | 4.553305e-6 |
GO:0021532 | neural tube patterning | 6.389563e-6 |
GO:0006700 | C21-steroid hormone biosynthetic process | 6.858110e-6 |
GO:0021587 | cerebellum morphogenesis | 8.398815e-6 |
GO:0030382 | sperm mitochondrion organization | 8.723773e-6 |
GO:0071453 | cellular response to oxygen levels | 9.817867e-6 |
GO:0050883 | musculoskeletal movement, spinal reflex action | 1.183995e-5 |
GO:0051336 | regulation of hydrolase activity | 1.302092e-5 |
GO:0006366 | transcription from RNA polymerase II promoter | 1.336492e-5 |
GO:0007498 | mesoderm development | 1.480875e-5 |
GO:0022415 | viral reproductive process | 1.895848e-5 |
GO:0048747 | muscle fiber development | 2.100345e-5 |
GO:0032423 | regulation of mismatch repair | 2.320325e-5 |
GO:0022601 | menstrual cycle phase | 2.388720e-5 |
GO:2000465 | regulation of glycogen (starch) synthase activity | 2.478089e-5 |
GO:0009790 | embryo development | 2.495547e-5 |
GO:0009953 | dorsal/ventral pattern formation | 2.952867e-5 |
GO:0072539 | T-helper 17 cell differentiation | 3.043051e-5 |
GO:0000266 | mitochondrial fission | 3.053737e-5 |
GO:0021683 | cerebellar granular layer morphogenesis | 3.324225e-5 |
GO:0035855 | megakaryocyte development | 3.622414e-5 |
GO:0046628 | positive regulation of insulin receptor signaling pathway | 3.664601e-5 |
GO:0060056 | mammary gland involution | 3.772261e-5 |
GO:0034698 | response to gonadotropin stimulus | 3.787115e-5 |
GO:0033083 | regulation of immature T cell proliferation | 3.922309e-5 |
GO:0014012 | peripheral nervous system axon regeneration | 3.950180e-5 |
GO:0090009 | primitive streak formation | 4.073642e-5 |
GO:0046325 | negative regulation of glucose import | 4.283956e-5 |
GO:0045585 | positive regulation of cytotoxic T cell differentiation | 4.319270e-5 |
GO:0030644 | cellular chloride ion homeostasis | 4.409628e-5 |
GO:2000467 | positive regulation of glycogen (starch) synthase activity | 4.501421e-5 |
GO:0090273 | regulation of somatostatin secretion | 4.963808e-5 |
GO:0006836 | neurotransmitter transport | 4.983516e-5 |
GO:0021750 | vestibular nucleus development | 5.668739e-5 |
GO:0021590 | cerebellum maturation | 5.668739e-5 |
GO:0021679 | cerebellar molecular layer development | 5.668739e-5 |
GO:0033121 | regulation of purine nucleotide catabolic process | 5.761217e-5 |
GO:0048255 | mRNA stabilization | 6.053259e-5 |
GO:0072104 | glomerular capillary formation | 6.492879e-5 |
GO:0048240 | sperm capacitation | 6.630684e-5 |
GO:0003310 | pancreatic A cell differentiation | 6.967547e-5 |
GO:0048008 | platelet-derived growth factor receptor signaling pathway | 7.251410e-5 |
GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process | 7.373451e-5 |
GO:0002052 | positive regulation of neuroblast proliferation | 7.880590e-5 |
GO:0045943 | positive regulation of transcription from RNA polymerase I promoter | 8.071215e-5 |
GO:0032354 | response to follicle-stimulating hormone stimulus | 8.187669e-5 |
GO:0048562 | embryonic organ morphogenesis | 8.365448e-5 |
GO:0060070 | canonical Wnt receptor signaling pathway | 8.380597e-5 |
GO:0032908 | regulation of transforming growth factor beta1 production | 8.392321e-5 |
GO:0046709 | IDP catabolic process | 8.477375e-5 |
GO:0046032 | ADP catabolic process | 8.477375e-5 |
GO:0001709 | cell fate determination | 9.074998e-5 |
GO:0010829 | negative regulation of glucose transport | 1.054765e-4 |
GO:0016079 | synaptic vesicle exocytosis | 1.218583e-4 |
GO:0007178 | transmembrane receptor protein serine/threonine kinase signaling pathway | 1.257122e-4 |
GO:0006704 | glucocorticoid biosynthetic process | 1.341621e-4 |
GO:0001704 | formation of primary germ layer | 1.363213e-4 |
GO:0030641 | regulation of cellular pH | 1.372187e-4 |
GO:0000052 | citrulline metabolic process | 1.531683e-4 |
GO:0014051 | gamma-aminobutyric acid secretion | 1.577676e-4 |
GO:0046031 | ADP metabolic process | 1.577676e-4 |
GO:0051956 | negative regulation of amino acid transport | 1.601515e-4 |
GO:0003006 | developmental process involved in reproduction | 1.627474e-4 |
GO:0016926 | protein desumoylation | 1.635792e-4 |
GO:0035659 | Wnt receptor signaling pathway involved in wound healing, spreading of epidermal cells | 1.645748e-4 |
GO:0014719 | satellite cell activation | 1.645748e-4 |
GO:0071545 | inositol phosphate catabolic process | 1.763711e-4 |
GO:0033084 | regulation of immature T cell proliferation in thymus | 1.763711e-4 |
GO:0007626 | locomotory behavior | 1.814073e-4 |
GO:0060415 | muscle tissue morphogenesis | 2.006781e-4 |
GO:0045750 | positive regulation of S phase of mitotic cell cycle | 2.017419e-4 |
GO:0046677 | response to antibiotic | 2.056332e-4 |
GO:2000054 | negative regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification | 2.226565e-4 |
GO:0031102 | neuron projection regeneration | 2.226805e-4 |
GO:0006972 | hyperosmotic response | 2.239359e-4 |
GO:0009948 | anterior/posterior axis specification | 2.399703e-4 |
GO:0072102 | glomerulus morphogenesis | 2.413604e-4 |
GO:0007109 | cytokinesis, completion of separation | 2.527791e-4 |
GO:0031103 | axon regeneration | 2.553557e-4 |
GO:0060393 | regulation of pathway-restricted SMAD protein phosphorylation | 2.621806e-4 |
GO:0045085 | negative regulation of interleukin-2 biosynthetic process | 2.623528e-4 |
GO:0060021 | palate development | 2.629027e-4 |
GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase cascade | 2.705772e-4 |
GO:0009653 | anatomical structure morphogenesis | 2.846271e-4 |
GO:0032922 | circadian regulation of gene expression | 2.914592e-4 |
GO:0003309 | type B pancreatic cell differentiation | 2.974648e-4 |
GO:0044087 | regulation of cellular component biogenesis | 3.025971e-4 |
GO:0030574 | collagen catabolic process | 3.046772e-4 |
GO:0030004 | cellular monovalent inorganic cation homeostasis | 3.367279e-4 |
GO:0007286 | spermatid development | 3.404373e-4 |
GO:0090244 | Wnt receptor signaling pathway involved in somitogenesis | 3.419895e-4 |
GO:0015812 | gamma-aminobutyric acid transport | 3.458402e-4 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 3.526960e-4 |
GO:0030326 | embryonic limb morphogenesis | 3.558782e-4 |
GO:0051893 | regulation of focal adhesion assembly | 3.614997e-4 |
GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c | 3.638458e-4 |
GO:0042326 | negative regulation of phosphorylation | 3.708501e-4 |
GO:0007224 | smoothened signaling pathway | 3.781985e-4 |
GO:0055008 | cardiac muscle tissue morphogenesis | 3.860233e-4 |
GO:0006979 | response to oxidative stress | 3.966183e-4 |
GO:0002238 | response to molecule of fungal origin | 4.024394e-4 |
GO:0071372 | cellular response to follicle-stimulating hormone stimulus | 4.680271e-4 |
GO:0031329 | regulation of cellular catabolic process | 4.708888e-4 |
GO:0009635 | response to herbicide | 4.813119e-4 |
GO:0035094 | response to nicotine | 4.895759e-4 |
GO:0007269 | neurotransmitter secretion | 4.899069e-4 |
GO:0045109 | intermediate filament organization | 4.942358e-4 |
GO:0010799 | regulation of peptidyl-threonine phosphorylation | 5.070145e-4 |
GO:0008217 | regulation of blood pressure | 5.167745e-4 |
GO:0044332 | Wnt receptor signaling pathway involved in dorsal/ventral axis specification | 5.177734e-4 |
GO:0046092 | deoxycytidine metabolic process | 5.177734e-4 |
GO:0035990 | tendon cell differentiation | 5.177734e-4 |
GO:0010970 | microtubule-based transport | 5.181783e-4 |
GO:0042775 | mitochondrial ATP synthesis coupled electron transport | 5.182635e-4 |
GO:0006909 | phagocytosis | 5.211240e-4 |
GO:0051925 | regulation of calcium ion transport via voltage-gated calcium channel activity | 5.260667e-4 |
GO:0051604 | protein maturation | 5.275184e-4 |
GO:0030320 | cellular monovalent inorganic anion homeostasis | 5.613454e-4 |
GO:0060218 | hemopoietic stem cell differentiation | 5.613847e-4 |
GO:0001501 | skeletal system development | 5.613954e-4 |
GO:0021578 | hindbrain maturation | 5.718296e-4 |
GO:0060338 | regulation of type I interferon-mediated signaling pathway | 5.726295e-4 |
GO:0043279 | response to alkaloid | 5.797208e-4 |
GO:0009894 | regulation of catabolic process | 5.951952e-4 |
GO:0032911 | negative regulation of transforming growth factor beta1 production | 5.994313e-4 |
GO:0015804 | neutral amino acid transport | 6.038662e-4 |
GO:0009299 | mRNA transcription | 6.231191e-4 |
GO:0010717 | regulation of epithelial to mesenchymal transition | 6.270398e-4 |
GO:0015747 | urate transport | 6.591121e-4 |
GO:2000164 | negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis | 6.614933e-4 |
GO:2000162 | negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis | 6.614933e-4 |
GO:2000166 | negative regulation of planar cell polarity pathway involved in pericardium morphogenesis | 6.614933e-4 |
GO:2000168 | negative regulation of planar cell polarity pathway involved in neural tube closure | 6.614933e-4 |
GO:0061310 | canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development | 6.614933e-4 |
GO:2000055 | positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification | 6.614933e-4 |
GO:2000149 | negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis | 6.614933e-4 |
GO:2000151 | negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis | 6.614933e-4 |
GO:0000578 | embryonic axis specification | 6.725449e-4 |
GO:0061088 | regulation of sequestering of zinc ion | 6.796650e-4 |
GO:0030219 | megakaryocyte differentiation | 6.840557e-4 |
GO:0050917 | sensory perception of umami taste | 6.976698e-4 |
GO:0033091 | positive regulation of immature T cell proliferation | 7.108368e-4 |
GO:0032535 | regulation of cellular component size | 7.301978e-4 |
GO:0030099 | myeloid cell differentiation | 7.341241e-4 |
GO:0006119 | oxidative phosphorylation | 7.344535e-4 |
GO:0021533 | cell differentiation in hindbrain | 7.508856e-4 |
GO:0048268 | clathrin coat assembly | 7.552075e-4 |
GO:0060235 | lens induction in camera-type eye | 7.676915e-4 |
GO:0034655 | nucleobase-containing compound catabolic process | 7.757800e-4 |
GO:0043487 | regulation of RNA stability | 8.027988e-4 |
GO:0045576 | mast cell activation | 8.429775e-4 |
GO:0072215 | regulation of metanephros development | 8.434609e-4 |
GO:0010898 | positive regulation of triglyceride catabolic process | 8.622557e-4 |
GO:0032674 | regulation of interleukin-5 production | 8.913903e-4 |
GO:0001938 | positive regulation of endothelial cell proliferation | 9.305897e-4 |
GO:0021696 | cerebellar cortex morphogenesis | 9.331005e-4 |
GO:0017145 | stem cell division | 9.363973e-4 |
GO:0072125 | negative regulation of glomerular mesangial cell proliferation | 9.400231e-4 |
GO:0071634 | regulation of transforming growth factor beta production | 9.446036e-4 |
GO:0060231 | mesenchymal to epithelial transition | 9.477801e-4 |
GO:0000432 | positive regulation of transcription from RNA polymerase II promoter by glucose | 9.588229e-4 |
GO:0003231 | cardiac ventricle development | 9.823948e-4 |
GO:0051955 | regulation of amino acid transport | 1.009146e-3 |
GO:0050881 | musculoskeletal movement | 1.016646e-3 |
GO:0019682 | glyceraldehyde-3-phosphate metabolic process | 1.060727e-3 |
GO:0021978 | telencephalon regionalization | 1.061850e-3 |
GO:0035793 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway | 1.062883e-3 |
GO:0048678 | response to axon injury | 1.064817e-3 |
GO:0072124 | regulation of glomerular mesangial cell proliferation | 1.076052e-3 |
GO:0018963 | phthalate metabolic process | 1.076052e-3 |
GO:0008344 | adult locomotory behavior | 1.090105e-3 |
GO:0009261 | ribonucleotide catabolic process | 1.093795e-3 |
GO:0030501 | positive regulation of bone mineralization | 1.111586e-3 |
GO:0000302 | response to reactive oxygen species | 1.131457e-3 |
GO:2000117 | negative regulation of cysteine-type endopeptidase activity | 1.131865e-3 |
GO:0032425 | positive regulation of mismatch repair | 1.131865e-3 |
GO:0009150 | purine ribonucleotide metabolic process | 1.143873e-3 |
GO:0006901 | vesicle coating | 1.149966e-3 |
GO:0003009 | skeletal muscle contraction | 1.177502e-3 |
GO:0070169 | positive regulation of biomineral tissue development | 1.200640e-3 |
GO:0061038 | uterus morphogenesis | 1.206509e-3 |
GO:0042789 | mRNA transcription from RNA polymerase II promoter | 1.212199e-3 |
GO:0002077 | acrosome matrix dispersal | 1.212199e-3 |
GO:0051952 | regulation of amine transport | 1.225012e-3 |
GO:0009620 | response to fungus | 1.226592e-3 |
GO:0051896 | regulation of protein kinase B signaling cascade | 1.235675e-3 |
GO:0071397 | cellular response to cholesterol | 1.243517e-3 |
GO:0072012 | glomerulus vasculature development | 1.253329e-3 |
GO:0050792 | regulation of viral reproduction | 1.255382e-3 |
GO:0034101 | erythrocyte homeostasis | 1.257475e-3 |
GO:0042773 | ATP synthesis coupled electron transport | 1.260173e-3 |
GO:0043488 | regulation of mRNA stability | 1.279754e-3 |
GO:0021904 | dorsal/ventral neural tube patterning | 1.280292e-3 |
GO:0009651 | response to salt stress | 1.305435e-3 |
GO:0070647 | protein modification by small protein conjugation or removal | 1.334933e-3 |
GO:0009154 | purine ribonucleotide catabolic process | 1.371002e-3 |
GO:0016082 | synaptic vesicle priming | 1.386313e-3 |
GO:0009166 | nucleotide catabolic process | 1.420764e-3 |
GO:0032989 | cellular component morphogenesis | 1.425579e-3 |
GO:0060444 | branching involved in mammary gland duct morphogenesis | 1.425591e-3 |
GO:0015802 | basic amino acid transport | 1.461026e-3 |
GO:0045936 | negative regulation of phosphate metabolic process | 1.462159e-3 |
GO:0048266 | behavioral response to pain | 1.464479e-3 |
GO:0060242 | contact inhibition | 1.475822e-3 |
GO:0044270 | cellular nitrogen compound catabolic process | 1.477024e-3 |
GO:0030220 | platelet formation | 1.514086e-3 |
GO:0048639 | positive regulation of developmental growth | 1.533736e-3 |
GO:0051412 | response to corticosterone stimulus | 1.575831e-3 |
GO:0032849 | positive regulation of cellular pH reduction | 1.578916e-3 |
GO:0007512 | adult heart development | 1.579809e-3 |
GO:0072198 | mesenchymal cell proliferation involved in ureter development | 1.595506e-3 |
GO:0072192 | ureter epithelial cell differentiation | 1.595506e-3 |
GO:0072138 | mesenchymal cell proliferation involved in ureteric bud development | 1.595506e-3 |
GO:0072101 | specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway | 1.595506e-3 |
GO:2000137 | negative regulation of cell proliferation involved in heart morphogenesis | 1.595506e-3 |
GO:2000007 | negative regulation of metanephric comma-shaped body morphogenesis | 1.595506e-3 |
GO:2000005 | negative regulation of metanephric S-shaped body morphogenesis | 1.595506e-3 |
GO:0090194 | negative regulation of glomerulus development | 1.595506e-3 |
GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis | 1.595506e-3 |
GO:0072200 | negative regulation of mesenchymal cell proliferation involved in ureter development | 1.595506e-3 |
GO:0060502 | epithelial cell proliferation involved in lung morphogenesis | 1.595506e-3 |
GO:0072097 | negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway | 1.595506e-3 |
GO:0048392 | intermediate mesodermal cell differentiation | 1.595506e-3 |
GO:0007500 | mesodermal cell fate determination | 1.595506e-3 |
GO:0060503 | bud dilation involved in lung branching | 1.595506e-3 |
GO:0055020 | positive regulation of cardiac muscle fiber development | 1.595506e-3 |
GO:0071893 | BMP signaling pathway involved in nephric duct formation | 1.595506e-3 |
GO:0061155 | pulmonary artery endothelial tube morphogenesis | 1.595506e-3 |
GO:0061151 | BMP signaling pathway involved in renal system segmentation | 1.595506e-3 |
GO:0061149 | BMP signaling pathway involved in ureter morphogenesis | 1.595506e-3 |
GO:0035166 | post-embryonic hemopoiesis | 1.612984e-3 |
GO:0009205 | purine ribonucleoside triphosphate metabolic process | 1.620877e-3 |
GO:0048644 | muscle organ morphogenesis | 1.631982e-3 |
GO:0046855 | inositol phosphate dephosphorylation | 1.633110e-3 |
GO:0032506 | cytokinetic process | 1.697126e-3 |
GO:0070309 | lens fiber cell morphogenesis | 1.719315e-3 |
GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle | 1.729132e-3 |
GO:0009199 | ribonucleoside triphosphate metabolic process | 1.735081e-3 |
GO:0048549 | positive regulation of pinocytosis | 1.823289e-3 |
GO:0061005 | cell differentiation involved in kidney development | 1.841396e-3 |
GO:0032909 | regulation of transforming growth factor beta2 production | 1.843628e-3 |
GO:0072262 | metanephric glomerular mesangial cell proliferation involved in metanephros development | 1.854667e-3 |
GO:0010810 | regulation of cell-substrate adhesion | 1.869411e-3 |
GO:0060024 | rhythmic synaptic transmission | 1.897720e-3 |
GO:0001933 | negative regulation of protein phosphorylation | 1.941620e-3 |
GO:0016485 | protein processing | 1.950679e-3 |
GO:0072112 | glomerular visceral epithelial cell differentiation | 1.983705e-3 |
GO:0006195 | purine nucleotide catabolic process | 2.032651e-3 |
GO:0002062 | chondrocyte differentiation | 2.054537e-3 |
GO:0007029 | endoplasmic reticulum organization | 2.059527e-3 |
GO:0072203 | cell proliferation involved in metanephros development | 2.110544e-3 |
GO:0048333 | mesodermal cell differentiation | 2.200282e-3 |
GO:0035524 | proline transmembrane transport | 2.202829e-3 |
GO:0021985 | neurohypophysis development | 2.211550e-3 |
GO:0000238 | zygotene | 2.211550e-3 |
GO:0007023 | post-chaperonin tubulin folding pathway | 2.211550e-3 |
GO:0006436 | tryptophanyl-tRNA aminoacylation | 2.255279e-3 |
GO:0046856 | phosphatidylinositol dephosphorylation | 2.333322e-3 |
GO:0016032 | viral reproduction | 2.354528e-3 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 2.378303e-3 |
GO:0019060 | intracellular transport of viral proteins in host cell | 2.406260e-3 |
GO:0046967 | cytosol to ER transport | 2.406260e-3 |
GO:0014057 | positive regulation of acetylcholine secretion | 2.406260e-3 |
GO:0010045 | response to nickel ion | 2.406260e-3 |
GO:0001980 | regulation of systemic arterial blood pressure by ischemic conditions | 2.406260e-3 |
GO:0044243 | multicellular organismal catabolic process | 2.436544e-3 |
GO:0048548 | regulation of pinocytosis | 2.495961e-3 |
GO:0032780 | negative regulation of ATPase activity | 2.495961e-3 |
GO:0046839 | phospholipid dephosphorylation | 2.514416e-3 |
GO:0060059 | embryonic retina morphogenesis in camera-type eye | 2.526825e-3 |
GO:0043503 | skeletal muscle fiber adaptation | 2.553533e-3 |
GO:0042744 | hydrogen peroxide catabolic process | 2.555070e-3 |
GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process | 2.568181e-3 |
GO:0050996 | positive regulation of lipid catabolic process | 2.576059e-3 |
GO:0032352 | positive regulation of hormone metabolic process | 2.620559e-3 |
GO:0032350 | regulation of hormone metabolic process | 2.652351e-3 |
GO:0052312 | modulation of transcription in other organism involved in symbiotic interaction | 2.703587e-3 |
GO:0032811 | negative regulation of epinephrine secretion | 2.723914e-3 |
GO:0048265 | response to pain | 2.727270e-3 |
GO:0032754 | positive regulation of interleukin-5 production | 2.745814e-3 |
GO:0019058 | viral infectious cycle | 2.760650e-3 |
GO:0009887 | organ morphogenesis | 2.768490e-3 |
GO:0090245 | axis elongation involved in somitogenesis | 2.774954e-3 |
GO:0021874 | Wnt receptor signaling pathway involved in forebrain neuroblast division | 2.774954e-3 |
GO:0016925 | protein sumoylation | 2.801958e-3 |
GO:0010629 | negative regulation of gene expression | 2.817203e-3 |
GO:0051385 | response to mineralocorticoid stimulus | 2.833857e-3 |
GO:0051216 | cartilage development | 2.842052e-3 |
GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus | 2.914696e-3 |
GO:0090169 | regulation of spindle assembly | 2.914696e-3 |
GO:0090234 | regulation of kinetochore assembly | 2.914696e-3 |
GO:0035444 | nickel ion transmembrane transport | 2.914696e-3 |
GO:0032148 | activation of protein kinase B activity | 2.922684e-3 |
GO:0021681 | cerebellar granular layer development | 2.922684e-3 |
GO:0032677 | regulation of interleukin-8 production | 2.931959e-3 |
GO:0006357 | regulation of transcription from RNA polymerase II promoter | 2.943595e-3 |
GO:0032967 | positive regulation of collagen biosynthetic process | 2.959062e-3 |
GO:0046543 | development of secondary female sexual characteristics | 3.001507e-3 |
GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport | 3.011477e-3 |
GO:2000242 | negative regulation of reproductive process | 3.011844e-3 |
GO:0009826 | unidimensional cell growth | 3.026819e-3 |
GO:0048610 | cellular process involved in reproduction | 3.027245e-3 |
GO:0002876 | positive regulation of chronic inflammatory response to antigenic stimulus | 3.029965e-3 |
GO:0006477 | protein sulfation | 3.043758e-3 |
GO:0043584 | nose development | 3.127175e-3 |
GO:0046034 | ATP metabolic process | 3.134741e-3 |
GO:2000683 | regulation of cellular response to X-ray | 3.285719e-3 |
GO:0003205 | cardiac chamber development | 3.311567e-3 |
GO:0051875 | pigment granule localization | 3.388995e-3 |
GO:0003208 | cardiac ventricle morphogenesis | 3.405904e-3 |
GO:2000611 | positive regulation of thyroid hormone generation | 3.412121e-3 |
GO:0033092 | positive regulation of immature T cell proliferation in thymus | 3.412121e-3 |
GO:0018879 | biphenyl metabolic process | 3.441908e-3 |
GO:0051453 | regulation of intracellular pH | 3.460078e-3 |
GO:0090342 | regulation of cell aging | 3.469332e-3 |
GO:0032412 | regulation of ion transmembrane transporter activity | 3.504702e-3 |
GO:0002027 | regulation of heart rate | 3.517654e-3 |
GO:0072384 | organelle transport along microtubule | 3.536121e-3 |
GO:0032689 | negative regulation of interferon-gamma production | 3.555401e-3 |
GO:0072668 | tubulin complex biogenesis | 3.585895e-3 |
GO:0009141 | nucleoside triphosphate metabolic process | 3.646290e-3 |
GO:0060279 | positive regulation of ovulation | 3.667546e-3 |
GO:0006868 | glutamine transport | 3.710811e-3 |
GO:0071480 | cellular response to gamma radiation | 3.710811e-3 |
GO:0072111 | cell proliferation involved in kidney development | 3.715845e-3 |
GO:0072523 | purine-containing compound catabolic process | 3.756330e-3 |
GO:0035850 | epithelial cell differentiation involved in kidney development | 3.778161e-3 |
GO:0043303 | mast cell degranulation | 3.809080e-3 |
GO:0003344 | pericardium morphogenesis | 3.814613e-3 |
GO:0015684 | ferrous iron transport | 3.831937e-3 |
GO:0031115 | negative regulation of microtubule polymerization | 3.867248e-3 |
GO:0048293 | regulation of isotype switching to IgE isotypes | 3.868983e-3 |
GO:0046700 | heterocycle catabolic process | 3.980750e-3 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 3.987679e-3 |
GO:0060981 | cell migration involved in coronary angiogenesis | 4.014298e-3 |
GO:0071670 | smooth muscle cell chemotaxis | 4.014298e-3 |
GO:2000016 | negative regulation of determination of dorsal identity | 4.014298e-3 |
GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity | 4.014298e-3 |
GO:0050916 | sensory perception of sweet taste | 4.014298e-3 |
GO:0022417 | protein maturation by protein folding | 4.014298e-3 |
GO:0006710 | androgen catabolic process | 4.014298e-3 |
GO:0023035 | CD40 signaling pathway | 4.014298e-3 |
GO:0021903 | rostrocaudal neural tube patterning | 4.116741e-3 |
GO:0043299 | leukocyte degranulation | 4.122110e-3 |
GO:0046637 | regulation of alpha-beta T cell differentiation | 4.194247e-3 |
GO:0010628 | positive regulation of gene expression | 4.223795e-3 |
GO:0009144 | purine nucleoside triphosphate metabolic process | 4.232106e-3 |
GO:0072098 | anterior/posterior pattern specification involved in kidney development | 4.243271e-3 |
GO:0002036 | regulation of L-glutamate transport | 4.243271e-3 |
GO:0048389 | intermediate mesoderm development | 4.243271e-3 |
GO:0014909 | smooth muscle cell migration | 4.243271e-3 |
GO:0043653 | mitochondrial fragmentation involved in apoptosis | 4.243271e-3 |
GO:0030513 | positive regulation of BMP signaling pathway | 4.310800e-3 |
GO:0051492 | regulation of stress fiber assembly | 4.316516e-3 |
GO:0090068 | positive regulation of cell cycle process | 4.332667e-3 |
GO:0034442 | regulation of lipoprotein oxidation | 4.374910e-3 |
GO:0010466 | negative regulation of peptidase activity | 4.443063e-3 |
GO:0071108 | protein K48-linked deubiquitination | 4.488416e-3 |
GO:0060686 | negative regulation of prostatic bud formation | 4.488416e-3 |
GO:0048103 | somatic stem cell division | 4.497712e-3 |
GO:0060689 | cell differentiation involved in salivary gland development | 4.507045e-3 |
GO:0032400 | melanosome localization | 4.526659e-3 |
GO:0023061 | signal release | 4.536143e-3 |
GO:0072015 | glomerular visceral epithelial cell development | 4.553791e-3 |
GO:0009259 | ribonucleotide metabolic process | 4.571068e-3 |
GO:0017156 | calcium ion-dependent exocytosis | 4.582904e-3 |
GO:0043932 | ossification involved in bone remodeling | 4.621052e-3 |
GO:0009235 | cobalamin metabolic process | 4.621052e-3 |
GO:0015862 | uridine transport | 4.621052e-3 |
GO:0019048 | virus-host interaction | 4.621811e-3 |
GO:0045893 | positive regulation of transcription, DNA-dependent | 4.689531e-3 |
GO:0044140 | negative regulation of growth of symbiont on or near host surface | 4.702392e-3 |
GO:0070086 | ubiquitin-dependent endocytosis | 4.702392e-3 |
GO:0042703 | menstruation | 4.702392e-3 |
GO:0006780 | uroporphyrinogen III biosynthetic process | 4.702392e-3 |
GO:0006121 | mitochondrial electron transport, succinate to ubiquinone | 4.702392e-3 |
GO:0018293 | protein-FAD linkage | 4.702392e-3 |
GO:0019101 | female somatic sex determination | 4.702392e-3 |
GO:0016486 | peptide hormone processing | 4.760393e-3 |
GO:0032736 | positive regulation of interleukin-13 production | 4.781460e-3 |
GO:0035518 | histone H2A monoubiquitination | 4.788797e-3 |
GO:0021979 | hypothalamus cell differentiation | 4.791786e-3 |
GO:0018931 | naphthalene metabolic process | 4.791786e-3 |
GO:0001675 | acrosome assembly | 4.810256e-3 |
GO:0030048 | actin filament-based movement | 4.815916e-3 |
GO:0042733 | embryonic digit morphogenesis | 4.889895e-3 |
GO:0031113 | regulation of microtubule polymerization | 4.907271e-3 |
GO:0030970 | retrograde protein transport, ER to cytosol | 4.909228e-3 |
GO:0061156 | pulmonary artery morphogenesis | 4.960362e-3 |
GO:0051851 | modification by host of symbiont morphology or physiology | 4.975327e-3 |
GO:0045066 | regulatory T cell differentiation | 4.985883e-3 |
GO:0001657 | ureteric bud development | 5.007575e-3 |
GO:0046849 | bone remodeling | 5.019813e-3 |
GO:0051897 | positive regulation of protein kinase B signaling cascade | 5.020476e-3 |
GO:2000664 | positive regulation of interleukin-5 secretion | 5.144892e-3 |
GO:2000667 | positive regulation of interleukin-13 secretion | 5.144892e-3 |
GO:2000703 | negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation | 5.144892e-3 |
GO:2000734 | negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation | 5.144892e-3 |
GO:2000607 | negative regulation of cell proliferation involved in mesonephros development | 5.144892e-3 |
GO:0001806 | type IV hypersensitivity | 5.144892e-3 |
GO:0060014 | granulosa cell differentiation | 5.144892e-3 |
GO:0060374 | mast cell differentiation | 5.144892e-3 |
GO:0034445 | negative regulation of plasma lipoprotein particle oxidation | 5.161120e-3 |
GO:0060430 | lung saccule development | 5.188730e-3 |
GO:0021794 | thalamus development | 5.202393e-3 |
GO:0035162 | embryonic hemopoiesis | 5.237584e-3 |
GO:0045069 | regulation of viral genome replication | 5.243195e-3 |
GO:0002524 | hypersensitivity | 5.293359e-3 |
GO:0007018 | microtubule-based movement | 5.314526e-3 |
GO:0009207 | purine ribonucleoside triphosphate catabolic process | 5.355257e-3 |
GO:0035249 | synaptic transmission, glutamatergic | 5.357169e-3 |
GO:0051253 | negative regulation of RNA metabolic process | 5.360842e-3 |
GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation | 5.364825e-3 |
GO:0042538 | hyperosmotic salinity response | 5.364825e-3 |
GO:0050748 | negative regulation of lipoprotein metabolic process | 5.373965e-3 |
GO:0023019 | signal transduction involved in regulation of gene expression | 5.441205e-3 |
GO:0090101 | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 5.444707e-3 |
GO:0008361 | regulation of cell size | 5.444707e-3 |
GO:0048704 | embryonic skeletal system morphogenesis | 5.525980e-3 |
GO:0060390 | regulation of SMAD protein import into nucleus | 5.619940e-3 |
GO:0071407 | cellular response to organic cyclic compound | 5.676536e-3 |
GO:0006635 | fatty acid beta-oxidation | 5.715805e-3 |
GO:0071276 | cellular response to cadmium ion | 5.753456e-3 |
GO:0043647 | inositol phosphate metabolic process | 5.775620e-3 |
GO:0051271 | negative regulation of cellular component movement | 5.781867e-3 |
GO:0021549 | cerebellum development | 5.827911e-3 |
GO:0060676 | ureteric bud formation | 5.867448e-3 |
GO:0048729 | tissue morphogenesis | 5.871289e-3 |
GO:0032271 | regulation of protein polymerization | 5.911145e-3 |
GO:0045892 | negative regulation of transcription, DNA-dependent | 5.956709e-3 |
GO:0021861 | forebrain radial glial cell differentiation | 6.053397e-3 |
GO:0070271 | protein complex biogenesis | 6.064909e-3 |
GO:0060760 | positive regulation of response to cytokine stimulus | 6.065222e-3 |
GO:2000194 | regulation of female gonad development | 6.118789e-3 |
GO:0042474 | middle ear morphogenesis | 6.154323e-3 |
GO:0001578 | microtubule bundle formation | 6.198896e-3 |
GO:0061046 | regulation of branching involved in lung morphogenesis | 6.246684e-3 |
GO:0002438 | acute inflammatory response to antigenic stimulus | 6.265602e-3 |
GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing | 6.293433e-3 |
GO:0043401 | steroid hormone mediated signaling pathway | 6.329221e-3 |
GO:0045814 | negative regulation of gene expression, epigenetic | 6.363709e-3 |
GO:0030218 | erythrocyte differentiation | 6.389134e-3 |
GO:0090183 | regulation of kidney development | 6.394614e-3 |
GO:0033327 | Leydig cell differentiation | 6.494220e-3 |
GO:0070193 | synaptonemal complex organization | 6.505700e-3 |
GO:0033132 | negative regulation of glucokinase activity | 6.552719e-3 |
GO:0061181 | regulation of chondrocyte development | 6.552719e-3 |
GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity | 6.552719e-3 |
GO:0031658 | negative regulation of cyclin-dependent protein kinase activity involved in G1/S | 6.552719e-3 |
GO:0007092 | activation of mitotic anaphase-promoting complex activity | 6.552719e-3 |
GO:0090092 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 6.574590e-3 |
GO:0000904 | cell morphogenesis involved in differentiation | 6.624225e-3 |
GO:0021796 | cerebral cortex regionalization | 6.656027e-3 |
GO:0010594 | regulation of endothelial cell migration | 6.725611e-3 |
GO:0045995 | regulation of embryonic development | 6.745985e-3 |
GO:0061004 | pattern specification involved in kidney development | 6.899996e-3 |
GO:0006513 | protein monoubiquitination | 6.900905e-3 |